Beta-adrenergic antagonists in the treatment of patients with heart disease.
D000070:Acebutolol / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001986:Bronchial Spasm / Q000139:chemically induced; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008790:Metoprolol / Q000627:therapeutic use; D008945:Mitral Valve Prolapse / Q000188:drug therapy; D008946:Mitral Valve Stenosis / Q000188:drug therapy; D009248:Nadolol; D009422:Nervous System Diseases / Q000139:chemically induced; D010869:Pindolol / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011412:Propanolamines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013329:Structure-Activity Relationship; D013999:Timolol / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; D009248:Nadolol; D000070:Acebutolol; D013999:Timolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol; D008790:Metoprolol